PDF
ePub
Citation
Print
Abstract
Jerusalem artichoke (JA) mainly consists of inulin. In many experimental studies, inulin has been shown to be beneficial for decreasing glucose level. Therefore, JA is lately attracting wide attention as an anti-diabetic food. Therefore, many patients ingest JA in extract form. However, there are no published clinical studies in patients with diabetes to demonstrate benefit from the use of inulin-type fructans. We experienced a diabetes inpatient with acute hyperglycemia associated with JA. We could not control the patient's blood glucose in spite of addition and increment of insulin. We found that she had taken extracts of JA and recommended cessation. After discontinuing JA extracts, her blood glucose was well controlled in spite of discontinuation of insulin. Thus, in this patient, JA had actually increased blood glucose. We suggest that JA may be dangerous for use in diabetic patients.
References
1. Gaede P, Lund-Andersen H, Parving HH, Pedersen O. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med. 2008; 358:580–91.
2. Egede LE, Ye X, Zheng D, Silverstein MD. The prevalence and pattern of complementary and alternative medicine use in individuals with diabetes. Diabetes Care. 2002; 25:324–9.
3. Cho MR, Choue R. A study of folk remedies in type II diabetic patients. Korean J Nutrition. 1998; 31:1151–7.
4. Kim JL, Bae CR, Cha YS. Helianthus tuberosus extract has antidiabetes effects in HIT-T15 cells. J Korean Soc Food Sci Nutr. 2010; 39:31–5.
5. Kim HS, Han GD. Hypoglycemic and hepatoprotective effects of Jerusalem artichoke extracts on streptozotocin-induced diabetic rats. Food Sci Biotechnol. 2013; 22:1121–4.
6. Hong JS, Kang HJ, Park JH, Lee EM. Analysis of prescribing pattern and drug compliance in patients with diabetes mellitus. Wonju: Health Insurance Review and Assessment Service;2010.
7. Kim CG, Kim SI, Shin HK. Effect of fructooligosaccharide-inulin of Jerusalem artichoke on the growth of intestinal microorganisms of pig. Korean J Food Sci Technol. 1993; 25:395–9.
8. Kim SH. Jerusalem artichoke and inulin. J Korean Diabetes. 2014; 15:227–31.
9. Henle T. Protein-bound advanced glycation endproducts (AGEs) as bioactive amino acid derivatives in foods. Amino Acids. 2005; 29:313–22.
10. Kellow NJ, Coughlan MT, Savige GS, Reid CM. Effect of dietary prebiotic supplementation on advanced glycation, insulin resistance and inflammatory biomarkers in adults with prediabetes: a study protocol for a double-blind placebo-controlled randomised crossover clinical trial. BMC Endocr Disord. 2014; 14:55.
11. Bonsu NK, Johnson CS, McLeod KM. Can dietary fructans lower serum glucose? J Diabetes. 2011; 3:58–66.
12. Evert AB, Boucher JL, Cypress M, Dunbar SA, Franz MJ, Mayer-Davis EJ, Neumiller JJ, Nwankwo R, Verdi CL, Urbanski P, Yancy WS Jr. American Diabetes Association. Nutrition therapy recommendations for the management of adults with diabetes. Diabetes Care. 2013; 36:3821–42.
13. Meshcheriakova VA, Plotnikova OA, Sharafetdinov KhKh, Iatsyshina TA. Use of Jerusalem artichokes in diet therapy of patients with type II diabetes mellitus. Vopr Pitan. 1995; 3:24–7.
Table 1.
Capillary plasma glucose of the patient, measured by a glucometer
XML Download